The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.
Oct 14, 2022
0
21
French drug maker Sanofi said Monday a COVID booster shot it is developing with Britain's GlaxoSmithKline has produced positive results against Omicron and other variants in clinical trials.
Jun 13, 2022
0
7
French pharmaceuticals giant Sanofi said Wednesday that its COVID-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its rivals.
Feb 23, 2022
0
3
The EU's medicines watchdog said Tuesday it has started to evaluate Pfizer-BioNTech's COVID-19 booster shot for children aged 12 to 15 years.
Feb 8, 2022
0
2
A French court on Wednesday allowed a class-action lawsuit to go ahead against pharmaceutical giant Sanofi by families of victims of Depakine, an epilepsy drug that can severely damage foetal development.
Jan 5, 2022
0
13
French pharma giant Sanofi said Tuesday it had signed a billion-dollar deal to buy US-based biotech firm Amunix, which develops cancer treatments that enlist the body's immune system.
Dec 21, 2021
0
2
The European Union's drug regulator said it received an application from Novavax to authorize the American biotechnology company's coronavirus vaccine, a request that could significantly boost the continent's vaccine supplies ...
Nov 17, 2021
0
2
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against COVID-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
Sep 28, 2021
0
1
France's pharmaceutical giant Sanofi, which has lagged behind rivals in developing new generation mRNA Covid-19 vaccines, on Tuesday said it has purchased a US firm specialising in the technology.
Aug 3, 2021
0
142
The European Medicines Agency said Tuesday it had started a "rolling review" of France's Sanofi coronavirus jab, which could lead to authorisation for use in the European Union.
Jul 20, 2021
0
2
